Crosse point out that the FDA’s failure to review all class III devices through its most stringent premarket review process. Unless exempt by regulation, new devices must clear FDA premarket review through either the 510(k) premarket notification process. Crosse also mentioned the failure of the FDA to meet statutory requirements to inspect certain domestic establishments on a set schedule.